QDEL
Quidel Corp price
-0.96% Past Week
Market Cap
2.92B
Day’s Range
52W Range
Volume (3M)
1.18M
Price-Earnings Ratio
-1.56
Revenue
2.83B
Quidel Corp Latest News
Top Discussions
About Quidel Corp
Quidel Corp is an American biopharmaceutical company based in San Diego, California. It is engaged in the discovery, development, manufacture, and marketing of diagnostic healthcare products that are distributed to a worldwide customer base. The company has an administrative office in China as well as manufacturing, research, and development facilities across the US, Germany, and Ireland. The firm has been in operation since 1979 and brought its first products to market in 1983.
The organisation has a strong focus on immunoassay development, monoclonal antibody characterisation and development, automated manufacturing, and molecular assay development. The firm’s products span a few diagnostic categories including lateral flow tests, direct fluorescent antibodies (DFA) micro-titer production products, fluorescent immunoassay products, and molecular diagnostic products. The firm produced the world’s first FDA-cleared handheld molecular device, AmpliVue.
Quidel products are used in hospitals, clinical laboratories, doctor's offices, and specialist healthcare screening facilities. The firm also produces and distributes a line of over-the-counter pregnancy tests, branded as RapidVue. The firm is listed on the NASDAQ, where it publicly trades under the stock ticker QDEL.
Start receiving updates on the most recent Quidel Corp price movements when you add QDEL stock to your watchlist to easily monitor real-time changes.
Show MoreBrian J. Blaser, MBA
CEO
7.1K
Employees
2022
Founded
San Diego, California, US
HQ
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
54
Medium
Industry
Avg. 49
64
Environment
49
Social
54
Governance
Consensus
Moderate Buy
Price Target
40.00
People Also Bought
AAN The Aaron's Company Inc 0.20% 
FOXF Fox Factory Holding Corp. -3.13% 
VICR Vicor Corporation -1.07% 
CLVT Clarivate Plc 0.15% 
KLXE KLX Energy Services Holdings Inc -0.64%
QDEL Upcoming events
30
OCT
Earnings Report
Q4 2024
After Market Close